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The Impact of Chronic Diseases on Health Services and Quality of Life of a 
Chinese Population  
 
Abstract 
 
Background:  Chronic diseases are becoming the major global burden of disease.  
Information on their impact on health services and quality of life can facilitate the 
provision of appropriate care.  Objectives: To determine the self-reported prevalence 
of chronic diseases and their impact on health service utilisation and quality of life.  
Methods: A cross-sectional random telephone survey on 2410 Chinese adults from 
the general population in Hong Kong with a structured questionnaire and the SF-36 
Health Survey.  The effects of chronic diseases on consultation rates, hospitalisation 
risk and the SF-36 scores were analysed by multivariate stepwise regressions, 
controlling for sociodemographic variables and co-morbidity.  Results: 38% of 
subjects reported one or more chronic diseases with 59% of them below the age of 60.  
Chronic joint problems were the most common. Every additional chronic disease 
increased the annual number of consultations by 60% and the likelihood of 
hospitalisation in the last year by 79%.  Most chronic diseases had a negative impact 
on quality of life with the most associated with psychological problems. Conclusions:  
One in three Chinese adults in Hong Kong reported to have chronic diseases. The 
total number of chronic diseases had a linear relationship with service utilization, 
which could be a useful medical risk adjustment factor.  Enhancing quality of life 
should be an important aim in the management of chronic diseases.  
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 2
Introduction 
 
The success of life-saving technology and medical care has led to a 
paradoxical increase in the prevalence of chronic diseases and perpetuated sick lives 
more than healthy ones, which Ernest Gruenberg calls the failures of success [1]. It 
was projected that chronic diseases will become the major global burden of disease in 
the coming two decades [2].    Data from Western populations have shown that 
chronic diseases are associated with higher service utilization and poorer quality of 
life [3-6].     The change in morbidity pattern is expected to be the most rapid in Asia 
but there is little data on the burden of chronic diseases from this part of the world.   
Chronic diseases have become the major causes of hospital admissions and 
deaths in Hong Kong since 1971 [7-9].    A few recent studies have reported on the 
prevalence of chronic diseases in Hong Kong but the results are limited either to a few 
conditions [8],   the older population [10] or diseases that required regular follow-up 
[11], and none of them has evaluated the impact of chronic diseases on health services 
or quality of life.   
The aim of this study was to find out the impact of self-reported chronic 
diseases on health services and quality of life of the Chinese adult population in Hong 
Kong.   We would like to estimate the population-based self-reported prevalence of 
chronic diseases, find out if they were associated with higher health service utilisation 
rates, and what impact they had on quality of life.   
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Methods 
 
Study Design and Setting  
This was a cross-sectional random telephone survey of the general adult 
Chinese population in Hong Kong.  Ninety-five percent of the Hong Kong population 
are Chinese and 15% of them are 60 years or older.  All households in Hong Kong, 
except for the 0.1% who live on boats, have telephones and local calls are free of 
charge [12]. Lam et al have shown that the results of  telephone interviews were 
similar to that found in face-to-face household surveys [13] 
 
Sampling Method  
  Household telephone numbers were selected randomly by the computer from 
the Chinese Residential Telephone Directories that contained 90% of all residential 
telephone numbers in Hong Kong [14].   Trained interviewers called the households 
in the order of the random telephone list in the evening of each weekday from June 1 
to September 30, 1998.   Among those members who were present in the contacted 
household, only the person who last had his/her birthday and was eighteen years or 
above was surveyed.   
 
Sample 
The intended sample size was 2500, based on a power calculation for a standard 
error of percentage of no more than 2% at 95% confidence interval, assuming the 
prevalence was unknown.  A total of 7185 telephone numbers were attempted but 
4328 had to be excluded because 3957 were not answered despite three attempts, 
there were no eligible subjects in 266, and 105 were commercial or invalid numbers.    
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There were 2857 eligible subjects but 345 refused to participate; 2512 subjects were 
surveyed and 2410 completed the whole interview giving a final response rate of 
84.4% (2410/2857).  Table 1 shows that the sociodemographic characteristics of the 
subjects compared with the Hong Kong general population data [12].  
 
Survey Instrument and Outcome Measures 
The survey instrument consisted of a structured questionnaire on 
sociodemographic data, chronic morbidity and service utilisation rates, and the 
Chinese (HK) version of the 36 item Short-form Health Survey (SF-36)[15].  It took 
15 to 20 minutes to complete.   
Sociodemographic data that were collected included age, gender, educational 
level, marital status and social class by occupation [16].   Chronic morbidity was 
measured by the total number and diagnosis of self-reported chronic diseases.   Each 
subject was asked if he/she had ever been diagnosed for more than one month by a 
registered medical practitioner to have hypertension, diabetes mellitus, heart disease 
of any kind, stroke, chronic pulmonary disease (asthma or other chronic respiratory 
problems), chronic joint problem, psychological illness or any other chronic disease. 
The total number of chronic diseases was calculated by the summation of the number 
of positive responses to these questions.   
Service utilisation was measured by self-reported annual consultation rate 
(number of outpatient consultations in the past one year), monthly consultation rate 
(number of outpatient consultations in the past one month), hospitalisation rate (any 
admission into the hospital in the past one year), the need for regular medications and 
the need for regular medical consultations.  
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The SF-36 is a widely used health-related quality of life (HRQOL) measure that 
has been translated and validated on the adult Chinese population in Hong Kong [15].  
It measures eight domains of HRQOL: physical functioning (PF), role limitation due 
to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social 
functioning (SF), role limitation due to emotional problems (RE) and mental health 
status (MH); each with a scale ranging from zero to 100 with a higher score indicating 
better HRQOL [17].  
 
Data Analysis 
The effects of sociodemographic variables on the total number of chronic 
diseases was tested by multivariate forward stepwise linear regression.  Relevant 
multivariate forward stepwise linear or logistic regressions were carried out to 
determine the effects of the total number of chronic diseases or specific diagnosis on 
service utilisation rates or the SF-36 scores, controlling for sociodemographic 
variables and co-morbidity.  Subjects with unknown or missing data in any variable 
were excluded from the relevant regression analysis, resulting in different sample 
sizes in different regression models.   All data analyses were done by the SPSS-
Windows 8.0 programme[18].   
 6
Results 
 
Prevalence of Chronic Diseases 
Nine hundred and seventeen (38.0%) subjects reported 1416 chronic diseases, 
no chronic disease was reported by 1349 (56.0%) subjects and 144 (6.0%) people 
were not sure whether they had any.   Five hundred and forty-one (59.0%) of subjects 
with chronic diseases were below the age of 60 although the age-specific prevalence 
increased with age.   
Table 2 shows the prevalence of common chronic diseases by age-sex groups.  
The prevalence of most chronic diseases increased with age but psychological 
problems were most common (7.3%) in the 40-59 year-old group.   All diagnoses 
were more common in females, except for stroke and chronic pulmonary diseases.    
Two hundred and twenty five (9.3%) subjects reported a variety of other chronic 
diseases including allergic rhinitis, gastrointestinal diseases, skin problems, eye 
conditions and cancer.    
Multivariate linear regression showed that increasing age, being female and 
not currently married increased the number of chronic diseases but social class and 
education level had no independent effect (Table 3).  
 
 
Impact of Chronic Diseases on Health Service Utilisation  
The subjects reported 7953 consultations in the previous year and 1137 
consultations in the last month.  The chronically ill consumed 52.7% of all the annual 
consultations and 63.9% of the monthly consultations.  Table 4 shows that the 
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reported service utilisation rates of each chronic disease group were much higher than 
those of subjects who did not report any chronic disease.   
Table 5 shows the results of the multivariate stepwise regressions of 
consultation rates and hospitalisation risk on the total number of chronic diseases and 
specific diagnosis. The total number of chronic diseases had a linear correlation with 
consultation rates and hospitalisation risk. The presence of any chronic diagnosis, 
except for stroke, significantly increased the annual and/or monthly consultation rates.   
All chronic diseases except hypertension, joint problems and psychological illnesses 
increased the risk of hospitalisation significantly, the highest was associated with 
stroke.   
 
The Effects of Chronic Diseases on Health-related Quality of Life 
 Table 6 compares the unadjusted SF-36 scores of the different chronic disease 
groups.  Chronic diseases were associated with lower (poorer) SF-36 scores in all 
domains and the unadjusted effect sizes were generally large.   Multivariate regression 
analysis controlling for sociodemographic factors showed that every additional 
chronic disease reduced the SF-36 scores by 5 to 12 points (Table 7), which was 
equivalent to a moderate effect size of 0.4 standard deviations [19]  The effect of each 
chronic disease on the SF-36 scores, controlling for sociodemographic variables and 
co-morbidity, are also shown in Table 7.  
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Discussion 
  A reported prevalence of chronic diseases of 38% was close to the 43% found 
in Japan [20] and lower than the 53% in the United States [6]   A local   household 
survey among older adults found similar age-specific prevalence (41% in the 45-59 
age group and 72% in the 60 or above group), suggesting the results of this study 
were valid. [10].    Lo et al reported a much lower prevalence of 16.8% of chronic 
diseases because they included only those conditions that required regular doctor 
follow-up [11].   
 The majority of people with chronic diseases were in the working age group, 
contrary to the general impression that chronic diseases are mainly problems of the 
elderly.  This was because the absolute number of people in this age group was high 
in the population.  Hoffman et al also found that 60% of the chronically ill in the 
United States were in the age group of 18-64 [6].   Health care systems that subsidise 
only the elderly population will exclude the majority of the chronically ill.   
Five percent of the elderly and 7.3% of the middle-age subjects reported 
chronic psychological problems but the Census Household Survey found only 0.4% of 
the elderly admitting to have depression and provided no data for the middle-aged 
[10].  The discrepancy was because the present study included not only depression but 
also other psychological problems.   Many Chinese people are not familiar with the 
term depression and somatization, therefore, psychological problems tend to be under 
reported in Chinese populations [21, 22].  
 There was a linear correlation between consultation rates and the total number 
of chronic diseases, irrespective of the diagnosis. The number of annual consultations 
increased by 1.7 (60% of the baseline rate of people without chronic disease) per 
person for each additional diagnosis, after controlling for sociodemographic factors 
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(table 5).  The odds ratio of hospitalisation in the last year was 1.79, which is 
equivalent to about 79% increase in relative risk, for every additional chronic disease.  
The total number of chronic conditions can be used as a medical risk adjustment 
factor for service planning and resource allocation, if the predictive relationship and 
coefficients can be confirmed by prospective studies. 
  The lack of correlation between stroke and consultation rates could be a type 
II statistical error because the sample size of 21 might not have enough power to 
reach statistical significance.  Furthermore, 86% of the stroke subjects had co-existing 
hypertension, diabetes mellitus or heart disease the effects of which might have 
‘cashed in’ before stroke could be entered into the stepwise regression models.     
 Each chronic disease had a unique effect on different quality of life domains.  
As shown in other studies, psychological illnesses impair quality of life more than any 
other chronic disease [23-25].   It is anticipated that mental illnesses will become a 
major global burden of disease and cause of disability in the next two decades [26].   
Chronic joint problems affected quality of life as much as chronic pulmonary diseases 
and more than hypertension and diabetes mellitus did.   Unfortunately, they have been 
much neglected by Governments and the medical profession because they are rarely 
lethal and are often regarded as part of normal aging [25, 27, 28].   New models of 
care that incorporate the promotion of health-related quality of life (HRQOL) are 
needed for people with chronic diseases [2, 29, 30].  The enhancement of HRQOL is 
not only an end in itself, it can also be a means to reduce the demand on health 
services because there is an inverse relationship between HRQOL and service 
utilisation [3-6].   
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Limitations of the Study 
 
The study sample had a relatively lower proportion of middle-aged adults than 
the Hong Kong general population, probably because some working adults had not 
returned home during the time of the telephone calls.      
Self-reported morbidity and service utilisation data may not be totally accurate 
because of recall errors.  However, self-reporting is commonly used in population and 
household surveys [10, 13, 31, 32].   The reported prevalence of chronic diseases was 
likely to be a conservative estimate because only diagnoses that were recalled were 
counted. The service utilisation rates reported should not be interpreted as the actual 
rates but an indication of the utilisation pattern [5].   Despite these limitations, the 
results of the regression analyses should be valid because there was no suggestion of 
any systematic bias.   
The association between chronic diseases and service utilisation rates or 
quality of life found in this cross-sectional study might not be causal although it was 
suggestive.  Further prospective studies are needed to confirm the relationship and 
determine the predictive coefficients more accurately. 
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Conclusions 
 
Chronic diseases are common among Chinese adults in Hong Kong, affecting 
more than one in three people.   They significantly increase health service utilisation 
rates and impair quality of life.  The annual consultation rate increases by about 60% 
and hospitalisation risk increases by 79% for every additional condition.   
Each chronic disease has a unique influence on different domains of quality of 
life.  Management programmes need to be multi-dimensional and tailored to the 
special needs of each disease group.  The quality of life of a person may be further 
compromised if he/she has to divert much of his/her income from other life needs to 
pay for health services.  Therefore, a good health-care system must ensure that the 
chronically ill are not deprived of adequate care because of a lack of means.    
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 Table 1: Sociodemographic Characteristics of Study Sample Compared with the 
Hong Kong General Population  
 
__________________________________________________________________________________ 
   
Sample  Hong Kong Adults 20+ years  
N=2,410  N=4,959,100 
__________________________________________________________________________________ 
        
Age Group (years) 
18-39      47.2%   46.2% 
40-59     27.2%   34.3% 
60 or above      21.4%   19.5% 
Refused to answer       4.2%        0% 
 
 
Male      47.8%   48.9% 
Female      52.2%   51.1% 
 
Marital Status 
a) Now Married    58.0%   59.4% 
b) Never Married    33.8%   31.9% 
c) Widowed       5.8%     6.0% 
d) Divorced/Separated       1.3%     2.7% 
e) Refused to Answer      1.1%       0% 
 
Educational Level 
a) No Schooling       6.9%     8.4% 
b) Primary     22.3%   20.5%  
c) Secondary    52.2%   54.6% 
d) Tertiary        17.8%        16.4% 
e) Refused to Answer      0.9%        0% 
 
Social Class by Occupation 
a) Professional       3.1%     5.5%a 
b) Associate Professional   14.7%   26.0% b 
c) Skilled Worker    35.4%   33.5% c 
d) Semi-skilled Worker   24.6%   15.0% d 
e) Non-skilled Worker & unclassified  14.4%   19.8% e 
f) Refused to Answer       7.7%       0% 
_______________________________________________________________________________ 
 
 
Notes 
 
1. The distribution in occupation of subjects was not directly comparable to Hong Kong Census Data  
which used the International Standard Classification of Occupation:- 
a. Professionals. 
b. Associate professionals, administrators and managers.  
c. Craft workers, plant and machine operators and assemblers. 
d. service and shop sales workers. 
e. Workers in elementary occupation, agriculture and fishery, and unclassified.  
 
2.   Percentages may not add up to 100% because of rounding. 
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Table 2: The Prevalence (%) of Chronic Diseases by Age and Sex Groups 
 
_________________________________________________________________  
 
   Any  
Diagnosis     HT     DM  Heart Pulmonary    Stroke       Joint  Psycho 
_________________________________________________________________  
All Age 
 
Overall (n=2410)   38.0     11.2    4.6    3.9      5.3            0.9 19.6 3.9 
 
M ((n=1152)     32.5      9.3    3.8    3.2      5.7           1.2 14.6 2.9 
 
F  (n=1258)   43.2    13.0    5.2    4.5      4.9               0.6        24.2 4.8 
_________________________________________________________________  
 
Age 18-39               
 
Overall (1137)   20.5       1.8     0.9    1.4      5.2            0     6.9 1.6        
 
M (n=601)   19.3       1.2      0.8    1.3      4.8            0               5.5  2.0                      
 
F  (n=536)          21.8       2.6      0.9    1.5           5.6            0  8.6  1.1  
_________________________________________________________________  
 
Age 40-59  
 
Overall (n=655)   47.0     13.1      4.1    2.4       5.8          0.8   26.0 7.3 
 
M (n=278)     37.8          10.4        4.0        1.8      6.5          0.7   18.7  4.0                   
 
F (n=377)        53.8     15.1      4.2    2.9      5.3          0.8  31.3 9.8 
_________________________________________________________________  
  
Age 60+ 
 
Overall (n=516)   68.0     30.2   13.8   11.4      5.0          3.1  42.1 5.2 
 
M (n=245)     60.0     27.3   11.0     9.4      6.5           4.9  33.9 4.1 
 
F  (n=271)   75.3     32.8   16.2   13.3      3.7          1.5  49.4 6.3 
_________________________________________________________________  
 
 
 
Notes 
 
1. 102 subjects refused to disclose their age. 
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Table 3: Effects of Sociodemographic Factors on the Total Number of Chronic 
Diseases 
 
 
__________________________________________________________________________________ 
 
Multivariate Forward Stepwise Linear Regressions  
__________________________________________________________________________________ 
Coefficientsa   Betab  P  R square changec 
 
Age      0.0251 0.478        <0.001  0.203  
 
 
Gender     0.191  0.104         <0.001  0.010 
(1=male, 2= female) 
 
Marital Status    0.118  0.063           0.003  0.003 
(1=married, 2=others) 
 
Social Class         ---    ---  ---    --- 
 
Education        ---    ---  ---    --- 
 
___________________________________________________________________  
Constant    -0.937 
 
 
Statistical Notes 
 
a. Regression coefficients of variables that were statistically significant at the 5% level are shown.  
The total number of chronic diseases can be estimated by summating the constant and the products 
of the value and regression coefficient of the independent variables.   
b. Beta is the standardised regression coefficient that indicates the change in standard units of the 
dependent variable for each increase of one standard unit in the independent variable. 
c. R square change is the proportion of variance in the dependent variable explained by the relevant 
independent variable. 
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Table 4:Distribution of  Service Utilisation Rates by the Number and Type of 
Chronic Diseases  
__________________________________________________________________________________ 
 
           No. Consultations   Proportion of Persons                                                             
       Annual      Monthly     Hospitalised       Regular  Regular            
                     Last Year      Consultations       Medications    
__________________________________________________________________________________ 
 
Total Sample             3.73         0.48                     4.5%              18.2%        16.6%    
    (n=2410)                
 
No Chronic Disease 
   (n=1349)             2.75          0.28         2.5%               4.3%         2.2%   
  
 
 ≥ 1 Chronic Disease 
   (n=917)            5.47                0.81         7.7%              40.9%        39.9%   
___________________________________________________________________________________  
 
Total Number of Chronic Disease  
         
One (n=579)             4.82         0.66                   5.9%               29.9%        27.3%         
     
Two (n=226)             5.43         0.82                   8.8%               56.2%        54.4%    
 
Three (n=79)             8.90              1.34                    8.9%               62.0%        70.9%    
 
Four  (n=20)             9.81              2.40          25.0%  80.0%        90.0%    
  
Five  (n=10)           0.50              1.50          40.0% 70.0%        80.0%   
 
Six  (n=3)           14.00            1.00          33.3%#  100%         100% 
________________________________________________________________________________ 
 
Specific Diagnosis 
 
HT (n=271)            6.68              0.81                      9.6%  64.2%        73.7%   
  
DM (n=110)            6.95              0.97        17.3% 77.3%           85.5%  
 
Heart (n=94)            7.10              1.36            17.0% 73.1%        77.4%  
  
Pulmonary  (n=128)      6.04              0.88                     14.2% 30.5%        28.9%  
 
Stroke (n=21)            7.18              0.89                   33.3%    100%        95.2%  
 
Joint  (n=473)            5.21              0.91                      6.1%  37.5%         34.0%   
 
Psychological (n=94)    6.69            1.30                8.5%  42.1%        41.5%  
 
Others (n=225)            6.81              0.95        8.0%  38.7%        36.0%  
__________________________________________________________________________________ 
 
 
Statistical Notes 
 
1. The differences in service utilisation rates between each disease group and the ‘no chronic 
disease’ group were statistically significant by the two-sample t tests or Chi square tests, except 
for the group marked with  # (p=0.06, Fisher’s Exact Test). 
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Table 5: Effects of Chronic Diseases on Service Utilisation Rates 
________________________________________________________________________________  
 
5a.Multivariate Stepwise Linear/Logistic Regressions on the Total Number of Chronic Diseasesa  
______________________________________________________________________________  
          Annual Consultation Rate Monthly Consultation Rate       Hospitalisation Risk 
         (N=1904)         (N=2107)       (N=2119)  
     
 Coefficientsc  Betad Coefficientsc  Betad          Odds Ratioe (95%CI) 
 
Per Chronic           1.724         0.341    0.309         0.248             1.791 (1.527, 2.100)) 
  Disease 
________________________________________________________________________________  
R2 Change f       0.117   0.065                 0.061 
  ________________________________________________________________________________  
 
_________________________________________________________________________________  
 
5b.Multivariate Stepwise Linear/Logistic Regressions on Chronic Diagnosisb 
_________________________________________________________________________________  
          Annual Consultation Rate Monthly Consultation Rate       Hospitalisation Risk 
         (N=1904)         (N=2107)       (N=2119)  
     
Coefficientsc  Betad    Coefficientsc  Betad          Odds Ratioe (95%CI) 
 
HT        2.534        0.172         ----  ----        ----  
 
DM        1.681         0.074                   ----       ----  3.448 (1.812, 6.560) 
 
Heart         ----           ----        0.521  0.086       2.212 (1.056, 4.634) 
 
Pulmonary       2.223         0.114              0.330        0.067  3.416 (1.868, 6.247) 
 
Stroke              ----        ----                ----         ----  5.776 (1.950, 17.116) 
 
Joint        0.954          0.083        0.312 0.110                   ---- 
 
Psychological            1.493         0.062             0.486 0.083                 ---- 
 
Others              1.742           0.112          0.400       0.104        1.894 (1.070, 3.353) 
_________________________________________________________________________________  
R2 Change f        0.125            0.067                       0.085 
_________________________________________________________________________________  
 
Statistical Notes 
 
a. The  total number of chronic diseases (continuous) and  all sociodemographic variables 
were entered as independent variables. 
b. Diagnosis (0=absent, 1=present) and all sociodemographic variables were entered as 
independent variables. 
c. Regression coefficients of variables that were statistically significant at the 5% level by 
multivariate linear regression.   
d. Beta is the standardised regression coefficient that indicates the change in standard units 
of the dependent variable for each increase of one standard unit in the independent 
variable by multivariate stepwise linear regression. . 
e. The odds ratios of variables that were statistically significant at the 5% level by 
multivariate stepwise logistic regression. 
f. R2 change is the proportion of variance in the dependent variable explained by the 
relevant independent variables shown. The Nagelkerke R square was used for the logistic 
regression models. 
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Table 6: Mean SF-36 Scores by Number of Chronic Diseases and Diagnosis 
 
__________________________________________________________________________________ 
      
PF  RP  BP GH  VT SF  RE  MH 
__________________________________________________________________________________ 
All subjects (N=2410) 
   Mean   91.83 82.43 83.98 55.98 60.27 91.19 71.66 72.79 
   S.D.   12.89 30.97 21.89 20.18 18.65 16.57 38.36 16.57 
 
No Chronic Disease (N=1349) 
   Mean    96.12 89.05 89.75 62.12 63.86 92.96 75.61 75.25 
   S.D.    6.89 24.68 17.21 17.60 17.42 14.27 35.98 14.71 
 
≥1 Chronic Disease (N=917)  
   Mean   85.07 71.78 75.49 46.88 55.25 88.81 65.98 69.67  
   Effect Size     0.86  0.56  0.65  0.76  0.46  0.25  0.25  0.34 
 
Hypertension (N=271)  
   Mean    80.89 71.40 76.40 46.34 56.68 88.98 68.02 71.57  
   Effect Size     1.18  0.57   0.61  0.78  0.38   0.24  0.20  0.22 
 
Diabetes mellitus (N=110)  
   Mean   77.36 63.86 72.31 40.76 55.09 86.59 67.27* 71.93# 
   Effect Size     1.46  0.81  0.80  1.06  0.47  0.38  0.22  0.20 
   
Heart disease (N=94)  
   Mean   72.55 57.98 67.85 35.04 50.16 84.04 60.99 67.62 
   Effect Size     1.83  1.00  1.00  1.34  0.73  0.54  0.38  0.46 
 
Pulmonary (N=128)   
    Mean   85.94 59.77 72.28 44.20 53.52 84.57 55.99 66.09 
    Effect Size     0.79  0.95  0.80  0.89  0.55  0.51  0.51  0.55   
 
Stroke (N=21)   
    Mean   68.57 58.33 66.48 34.10 55.48 79.76* 58.73# 68.38#    
Effect Size     2.14  0.99  1.06  1.39  0.45  0.80  0.44  0.41 
 
Joint (N=473) 
   Mean   81.58 68.39 70.90 44.70 52.93 88.42 65.12 68.80 
   Effect Size     1.13  0.67  0.86  0.86  0.59  0.27   0.27  0.39   
 
Psychological  (N=94) 
   Mean   82.55 55.05 70.49 37.10 44.52 80.32 51.06 55.66 
   Effect Size     1.05  1.10  0.88  1.24  1.04  0.76  0.64  1.18 
  
Others (N=225)  
   Mean   86.64 69.11 71.00 44.16 54.16 86.56 63.70 68.50 
   Effect Size     0.74  0.64  0.86  0.89  0.52  0.39  0.31  0.41 
__________________________________________________________________________________ 
 
 
Statistical Notes 
 
1. The differences in mean SF-36 scores between the disease group and people without any 
chronic disease were statistically significant with p<0.01, except for those marked with * 
(significant with p<0.05) or  # ( not significant with p>0.05) by the Two-sample  t  tests.   
2. Effect size= difference in mean score between the disease and 'no chronic disease' groups / 
S.D. of all subjects. 
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Table 7: Effects of Chronic Diseases on SF-36 Scores 
            
 
7a.  Multivariate Stepwise Linear Regression on the Total Number of Chronic Diseasesa  
            
Regression Coefficientc (Betad)    
N=2122     PF   RP    BP   GH    VT    SF    RE   MH 
 
Per Chronic              -5.16   -11.67  -8.48  -8.47  -5.92    -4.46  -9.76   -4.66 
Diseases              (-0.37) (-0.35)   (-0.35) (-0.38) (-0.29) (-0.25) (-0.23) (-0.26)  
            
 R2 Change e  0.274 0.118 0.127  0.162   0.055    0.030     0.017   0.029 
_______________________________________________________________________________  
 
            
 
          7b.  Multivariate Stepwise Linear Regression on Diagnosisb  
            
Regression Coefficientc (Betad)      
N=2122     PF   RP    BP   GH    VT    SF    RE   MH 
   
HT           -3.54      ----    ----   -3.70     ----   -2.94   -8.90   -2.91 
  (-0.08)     (-0.06)   (-0.06)  (-0.07)  (-0.06) 
 
DM          -4.12  -10.57   -6.52       -9.34     ----     -4.02     ----     ----  
   (-0.07)  (-0.07)  (-0.06)   (-0.10)    (-0.05) 
 
Heart   -8.67  -15.17     -7.79   -11.10   -7.16   -4.17      ----     ---- 
               (-0.13)  (-0.09)  (-0.07)   (-0.10)   (-0.07)   (-0.05) 
 
Pulmonary          -4.49  -18.79  -10.94    -9.75    -4.61       -5.28  -11.72   -5.02 
               (-0.08)  (-0.14)  (-0.11)   (-0.11)   (-0.06)   (-0.07)  (-0.07)    (-0.07)   
 
Stroke               -10.14    ----    ----      ----      ----    ----      ----     ---- 
               (-0.08) 
 
Joint              -6.56  -13.56    -13.26   -9.22     -8.76  -3.98 -12.65   -5.72 
             (-0.20)  (-0.17)  (-0.24)  (-0.18)  (-0.19)   (-0.10)   (-0.13)  (-0.14) 
 
Psychological              -4.62  -22.71  -5.85  -12.20    -13.94     -10.11   -20.91  -16.64 
             (-0.07)  (-0.14)    (-0.05)  (-0.12)   (-0.14)  (-0.12)  (-0.11)    (-0.19) 
 
Others        -3.06 -11.25  -11.87   -9.95   -5.47   -4.22   -8.41   -3.57 
  (-0.07)  (-0.11)  (-0.16)  (-0.14)  (-0.09)  (-0.08)  (-0.06)  (-0.06) 
_______________________________________________________________________________  
R2 Change e  0.128  0.131   0.141   0.164   0.077   0.052   0.046   0.077 
_______________________________________________________________________________  
 
 
Statistical Notes 
 
a. The  total number of chronic diseases (continuous) and  all sociodemographic variables were the 
independent variables. 
b. Diagnosis (0=absent, 1=present) and all sociodemographic variables were the independent 
variables. 
c. Regression coefficients of variables that were statistically significant at the 5% level are shown.   
d. Beta is the standardised regression coefficient that indicates the change in standard units of the 
dependent variable for each increase of one standard unit in the independent variable. 
e. The R2 change is the proportion of variance in the dependent variable that is explained by the 
relevant independent variables shown. 
